Recruiting Lupus Studies in Hershey
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Hydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication that has been very effective in reducing lupus disease activity and keeping patients stable with reduced symptoms. Despite a...
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease which often has debilitating and potentially life-threatening consequences. The cause of SLE is unknown and current therapies lack ...
About Lupus Clinical Trials in Hershey
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Hershey, PA. These studies are seeking a combined 620 participants. Research is being sponsored by NYU Langone Health, State University of New York - Upstate Medical University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Hershey — FAQ
Are there lupus clinical trials in Hershey?
Yes, there are 2 lupus clinical trials currently recruiting in Hershey, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hershey?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hershey research site will contact you about next steps.
Are clinical trials in Hershey free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hershey studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Hershey are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov